Skip to main content
Log in

Effect of the molsidomine metabolite SIN-1 on coronary arteries and peripheral vessels of sheep with special reference to tolerance and endothelium

  • Experimental Pharmacology
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

In vitro experiments on rings from coronary arteries, femoral arteries, and femoral veins of sheep were performed, and cumulative concentration-relaxation responses were established for glyceryl trinitrate (GTN) and the molsidomine metabolite SIN-1. Paired preparations of control and deendothelialized coronary artery rings were used, and the vessels were precontracted with different agonists at a concentration that elicited 30% of maximal contractions (EC-30). In coronary arteries, the responses for GTN and SIN-1 on normal and deendothelialized preparations were not significantly different. In coronary arteries preincubated with 0.44 mM GTN or SIN-1 to study tolerance development, there was a significant loss of efficacy to the relaxant effect of GTN, whereas the effect SIN-1 was essentially maintained. Femoral arteries and veins were readily relaxed with GTN and SIN-1. In veins relaxation in relation to resting tone was much more pronounced than in coronary or femoral arteries. In conclusion, the molsidomine metabolite SIN-1 is a potent coronary and venous vasodilator that does not induce tolerance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rapoport RM, Murad F. Endothelial-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle: Role of cyclic GMP.J Cycl Nucl Prot Phos Res 1983:9: 281–291.

    CAS  Google Scholar 

  2. Noack E, Feelisch M. Molecular aspects underlying the vasodilator action of molsidomine.J Cardiovasc Pharmacol 1989;14(Suppl. 11):S1-S5.

    PubMed  CAS  Google Scholar 

  3. Flaherty JT. Nitrate tolerance.Drugs 1989;37:527–550.

    Article  Google Scholar 

  4. Bohn H, Schönafinger K. Oxygen and oxidation promote the release of nitric oxide from sydnonimines.J Cardiovasc Pharmacol 1989;14(Suppl. 11):S6-S12.

    PubMed  CAS  Google Scholar 

  5. Bassenge E, Kukovetz WR. Molsidomine. In: Scriabine A, ed.New drugs annual. Cardiovascular drugs. Vol 2. New York: Raven Press, 1984:177–191.

    Google Scholar 

  6. Thulesius O. Cardiovascular pharmacology of molsidomine.Bibl Cardiol 1984;38:234–243.

    PubMed  CAS  Google Scholar 

  7. Thulesius O, Ugaily-Thulesius L, Neglen P, Shuhaiber H. The role of endothelium in the control of venous tone: Studies on isolated human veins.Clin Physiol 1988;8:359–366.

    Article  PubMed  CAS  Google Scholar 

  8. Thulesius O, Stephen FX. Computer assisted drug analysis of dose response curves with special reference to molsidomine.Gen Pharmac 1983;14:91–93.

    CAS  Google Scholar 

  9. Ljusegren ME, Ahlner J, Axelsson KL. Studies on vascular smooth muscle tolerance to different cGMP-mediated vasodilators and cross-tolerance to glyceryl trinitrate.Pharmacol Toxicol 1988;62:302–307.

    PubMed  CAS  Google Scholar 

  10. Shirasaki Y, Su C. Endothelium-removal augments vasodilatation by sodium nitroprusside and sodium nitrate.Eur J Pharmacol 1985;114:93–96.

    Article  PubMed  CAS  Google Scholar 

  11. Rafflenbeul W, Bassenge E, Lichtlen PR. Competition between endotheliumand nitroglycerin-induced coronary vasodilatation (abstract).Circulation 1988;78(Suppl. II):II455.

    Google Scholar 

  12. Pohl U, Holtz J, Busse R, Bassenge E. Crucial role of endothelium in the vasodilator response to increased flow in-vivo.Hypertension 1986;8:37–44.

    PubMed  CAS  Google Scholar 

  13. Ahlner J, Axelsson KL. Nitrates mode of action at a cellular level.Drugs 1987;33(Suppl. 4):32–38.

    Article  PubMed  CAS  Google Scholar 

  14. Keith RA Burkmann AM, Sokoloski TD, Fertel RH. Vascular tolerance to nitroglycerin and cyclic GMP generation in rat aortic smooth muscle.J Pharmacol Exp Ther 1983;221: 525–531.

    Google Scholar 

  15. Kukovetz WR, Holzmann S. Mechanism of nitrate-induced vasodilatation and tolerance.Z Kardiol 1983;72(Suppl. 3):14–19.

    PubMed  CAS  Google Scholar 

  16. Kukovetz WR, Holzmann S, Romanin C. Cyclic GMP and tolerance to nitrates. In: Vanhoutte PM, ed.Vasodilatation: vascular smooth muscle, peptides, autonomic nerves and endothelium. New York: Raven Press, 1988:49–54.

    Google Scholar 

  17. Axelsson KL, Andersson RGG, Wikberg JES. Vascular smooth muscle relaxation by nitrocompounds: Reduced relaxation and cGMP elevation in tolerant vessels and reversal of tolerance by dithiothreitol.Acta Pharmacol Toxicol 1982;50:350–357.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mariam, H., Yousif, F. & Thulesius, O. Effect of the molsidomine metabolite SIN-1 on coronary arteries and peripheral vessels of sheep with special reference to tolerance and endothelium. Cardiovasc Drug Ther 5, 769–773 (1991). https://doi.org/10.1007/BF03029753

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03029753

Key Words

Navigation